Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
about
Assessment of long-term renal complications in extremely low birth weight childrenLow birthweight and risk of albuminuria in living kidney donors.Prematurity-related hypertension in children and adolescents.Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy--A Retrospective Registry-Based Cohort Study.Are low birth weight neonates at risk for suboptimal renal growth and function during infancy?Developmental programming of hypertension and kidney diseaseCalcimimetics as an adjuvant treatment for familial hypophosphatemic ricketsRace-specific relationship of birth weight and renal function among healthy young childrenGross placental measures and childhood growth.Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.Developmental origins of chronic renal disease: an integrative hypothesis.Mechanistic analysis for time-dependent effects of cinacalcet on serum calcium, phosphorus, and parathyroid hormone levels in 5/6 nephrectomized rats.Parathyroid-specific interaction of the calcium-sensing receptor and G alpha q.Do mismatches between pre- and post-natal environments influence adult physiological functioning?Fetal first trimester growth is not associated with kidney outcomes in childhood.Preterm birth and the kidney: implications for long-term renal health.Proteinuria caused by glomerular hypertension during adolescence associated with extremely premature birth: a report of two cases.Prenatal programming of renal function: the estimated glomerular filtration rate is influenced by size at birth in apparently healthy children.Ultrasonographic study of initial size and postnatal growth of kidneys in preterm infants.A new serum cystatin C formula for estimating glomerular filtration rate in newborns.Prenatal programming of adult mineral metabolism: relevance to blood pressure, dietary prevention strategies, and cardiovascular disease.
P2860
Q34993575-9E01C044-6341-4373-9353-867B9DB1BF41Q35369145-FEFE28E2-9C28-488B-9DE1-6F3402246580Q35821231-DB6D91B1-EC13-46E2-B1EA-179288FDB2EFQ35993496-874DE74D-A667-4FAA-8AF6-189CBBBC7DFCQ36086615-E8635F43-329C-4051-B896-644EFA168389Q36449889-8A7B1642-8F60-4022-BF1F-92CBD0981EF8Q36662050-6DF592EF-2C6A-4101-94FB-212CECD107A3Q36954410-0A65EC36-DCDE-4687-AFE8-606A6BBFBF14Q37018605-5A5B7C93-61A2-4D01-8DB6-155A92387E26Q37095019-3F8327BF-7FF6-44EB-8DF1-CB6D48DA666DQ37171950-0BAB5BDD-A07B-4083-8C6B-8A2FC93A5CFAQ37328071-D1593F5D-D0FD-41AF-971A-7A4B57B00AE3Q37383741-25D77046-48DE-4613-B68E-49BD262DD6F4Q37538153-09103CE9-0052-45B1-AFBA-7D21184D0098Q37678065-3781F499-FA3D-4928-94C3-6BB6E7313848Q37856094-C5996F8D-CB10-4C12-A7D6-50771368FB52Q38989130-077CECED-CF17-4CDA-8239-5EA64ADA9E51Q46698288-37AFD0E4-9142-4611-B81F-F04ED1950836Q47172925-B2444056-5CFE-4DC8-8D28-6532D840415AQ50918012-8314A77F-2391-485E-9564-505F34C07104Q50988701-B6EFC864-E486-4AE0-AEE6-1686DB498AED
P2860
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@ast
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@en
type
label
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@ast
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@en
prefLabel
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@ast
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@en
P1476
Cinacalcet HCl: a novel treatm ...... tage 5 chronic kidney disease.
@en
P2093
L Darryl Quarles
P356
10.1111/J.1523-1755.2005.00451.X
P577
2005-07-01T00:00:00Z